2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Sunday, December 13, 2026
09:30 a.m. - 11:00 a.m.
MCCNO - 291-292
Technology and Procedures, Assays, Molecular Testing, Bioinformatics, Gene Editing, Treatment Considerations, Non-Biological Therapies, Pharmacology, Biological Processes, Pathogenesis, CHIP, Genomics, Hematopoiesis, Immune Mechanism, Molecular Biology, Multi-Systemic Interactions, Diseases, Bone Marrow Failure Syndromes, Inherited Marrow Failure Syndromes, Genetic Disorders, Myeloid Malignancies, Acute Myeloid Malignancies, Chronic Myeloid Malignancies, Research, Fundamental Science, Translational Research, MDS, Clinical Research, Epidemiology, Real-World Evidence, Study Population, Human, Adult, Elderly, Embryo/Fetus, Animal Model
PAPER

483 Asxl1 mutant progenitors outcompete Dnmt3a mutant cells in nutrient restricted conditions

Apoorva Thatavarty, BS, Marco Buttigieg, BSc2, Zhijian Yu3, Xiaochen Long, PhD4, Katie Matatall5, Spencer Redding6, Frieda Zimmer, MD7, Ruoqiong Cao, MS8, Arushana Maknojia, PhD9, Brandon Tran, PhD10, Hu Chen, PhD11, Marek Kimmel, PhD12, Michael Rauh, MD PhD13, Katherine Y King, MD, PhD14
1 Baylor College of Medicine, Houston, Texas, United States
2 Queen's University, Kingston, Ontario, Canada
3 Baylor College of Medicine, Houston, Texas, United States
4 Rice University, Houston, Texas, United States
5 Baylor College of Medicine, Houston, Texas, United States
6 Baylor College of Medicine, Houston, Texas, United States
7 Baylor College of Medicine, Houston, Texas, United States
8 Baylor College of Medicine, Houston, Texas, United States
9 Baylor College of Medicine, Houston, Texas, United States
10 Baylor College of Medicine, Houston, Texas, United States
11 Baylor College of Medicine, Houston, Texas, United States
12 Rice University, Houston, Texas, United States
13 Queen's University, Kingston, Ontario, Canada
14 Baylor College of Medicine, Houston, Texas, United States

Clonal hematopoiesis (CH) is ubiquitous among people over age 55, and 25% of aged individuals have multiple mutant clones (Fabre, Nature 2022). Most studies of CH have investigated mechanisms of clonal expansion one clone at a time; however, little is known about how emerging clones impact the expansion of neighboring clones.

Prior work showed that HSCs with mutations in DNMT3A, ASXL1, or TET2 (D-A-T), three genes commonly mutated in CH, have a selective advantage under inflammatory conditions. Selective advantage is achieved via enhanced cytokine production paired with mutation-specific mechanisms to survive inflammation, creating a feed-forward loop. We therefore hypothesized that D-A-T mutant clones cooperatively promote each other’s expansion.

Human Genetic Analysis Reveal ASXL1-DNMT3A Antagonism

We analyzed co-mutation patterns and clonal dynamics across 5 CH/MDS human cohorts. Contrary to our expectations, we observed a consistent and pronounced mutual exclusivity between DNMT3A and ASXL1 mutations across all datasets, with the strongest signal in UK Biobank (OR = 0.12, p = 3.97E-28) and All of Us (OR = 0.16, p = 6.3E-29). We used logistic regression models to test whether clone size influenced these dynamics. Interestingly, we observed that increasing ASXL1 VAF was associated with reduced odds of a DNMT3A co-mutation, while increasing DNMT3A VAF had no significant effect on ASXL1 detection. Combined, these data suggest a directional and dose-dependent suppressive effect by ASXL1 on DNMT3A clones.

Murine Models Support Directional Suppression

To model these interactions and investigate mechanisms, we generated a 1% mosaic competitive transplant murine model where Dnmt3a-/-, Tet2-/-, and Asxl1-truncation transgene cells were transplanted alone, pairwise (2x) and combined (3x). In line with our human data, the mosaic murine models showed Asxl1TG+ cells suppressed Dnmt3a-/-clonal expansion in both the blood and bone marrow. Statistical modeling revealed a 4% decrease in weekly growth rate for Dnmt3a-/- cells when in competition with Asxl1TG+. While we observed in vivo suppression of Dnmt3a-/- cells within the progenitor compartment in the 2x condition, ex vivo co-culture assays did not reproduce this suppression, suggesting that direct interactions between Asxl1TG+ and Dnmt3aKO/KO progenitors are not responsible for this effect.

To investigate the mechanism of Asxl1TG+ mediated Dnmt3a-/- suppression, we performed single cell RNA sequencing of lineage depleted Dnmt3a-/-, Asxl1TG+ and wild type (WT) bone marrow cells isolated from 1x and 2x transplants.Pathway enrichment analyses of Dnmt3a-/- HSCs when in the presence of Asxl1TG+ cells revealed upregulation of hypoxia and unfolded protein pathways but downregulation of stemness genes. Conversely, Asxl1TG+ HSCs were metabolically more active than WT and Dnmt3a-/- cells, and their downstream progeny, particularly neutrophils, had an elevated pro-inflammatory signature (IL-6, TNFa, IFNg) when in the presence of Dnmt3a-/- cells. However, when proinflammatory cytokines were added to co-culture assays, we found Dnmt3a-/- expansion was not suppressed by Asxl1TG+ cells, indicating inflammation alone does not explain the suppressive effects found in vivo.

Recent studies report Dnmt3a-mutant cells utilize oxidative phosphorylation to maintain a competitive advantage over WT cells. As a result, Dnmt3a-mutants are particularly sensitive to changes in metabolism. Based on these data and recent studies, we hypothesized that Asxl1TG+cells preferentially steal available nutrients to meet their elevated metabolic demands, thereby restricting Dnmt3a-/-growth. Indeed, we found that co-culturing Dnmt3a-/- and Asxl1TG+progenitors in nutrient restricted conditions suppressed Dnmt3a-/- growth compared to when co-cultured with WT cells. These data suggest that Asxl1TG+ HSCs effectively steal extracellular nutrients thus restricting the available resources to support Dnmt3a-/- HSC growth. Taken together, these data show that Dnmt3a-mutant clones thrive when nutrients are abundant, but their expansion is limited when metabolic resources are restricted such as in the presence of hypermetabolic progeny of an Asxl1TG+clone.

To our knowledge, this is the first epidemiologic and mechanistic report of inter-clonal dynamics that affect early clonal expansion. Collectively, these findings establish nutrient competition during inter-clonal interactions as an important regulator of clonal evolution.

Apoorva Thatavarty, BS: No relevant conflicts of interest to declare.